Fidelity International’s AC Immune ACIU Stock Holding History

Fidelity International’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,283,910	Closed	-$11.9M	–	920
2018 Q2	$11.9M	Buy	+1,283,910	New	+$12.7M	0.02%	469

Other funds holding ACIU

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Fidelity International's ACIU Position: Q3 2018 in Review

Fidelity International sold out of AC Immune (ACIU) in Q3 2018, closing a stake of 1,283,910 shares — an estimated $11.9M sold.

Fidelity International first reported a position in ACIU in Q2 2018 and held it in 1 quarter. The position peaked at $11.9M in Q2 2018. 32 funds tracked by Wall St. Rank hold ACIU as of Q3 2018.

Fidelity International reported no remaining AC Immune position as of Q3 2018 after selling out during the quarter.
Fidelity International sold 1,283,910 AC Immune shares in Q3 2018, an estimated $11.9M.
Fidelity International first reported a position in AC Immune in Q2 2018 and held it in 1 quarter.
Fidelity International's AC Immune position peaked at $11.9M in Q2 2018.
32 funds tracked by Wall St. Rank held AC Immune as of Q3 2018.

Based on Fidelity International's 13F filing for Q3 2018, filed 9 Nov 2018.